Therapeutic Drug Monitoring (TDM) of Biologics with Theradiag

Products are for professional/laboratory use only. TDM in Chronic Inflammatory Diseases (CID) Biologic therapies, and notably Monoclonal antibodies (mAbs) and Fusion Proteins (FP), have revolutionised the management of CID, such as Inflammatory Bowel Disease, Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriasis and Psoriatic Arthritis that affect millions of people worldwide.

Tocilizumab and COVID-19

Products are for professional/laboratory use only.  With the evolution of  COVID-19, Theradiag is committed to providing the medical community with the necessary products to aid in the COVID-19 response.

Update on British guidelines for management of IBD in adults

Products are for professional/laboratory use only. Please find below a summary of the recently published British guidelines on the management of inflammatory bowel disease in adults.

Theradiag LISA TRACKER for determination of ustekinumab in Crohn’s disease

Products are for professional/laboratory use only. Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn’s Disease. Painchart C, Brabant S et al; Dig Dis Sci. 2019 Oct 10.

Theradiag UEG Week Abstract

Products are for professional/laboratory use only. Systematic review with meta-analysis: association between vedolizumab trough concentration and clinical outcomes in patients with inflammatory bowel diseases.

Theradiag LISA TRACKER – leaders in Therapeutic Drug Monitoring

Products are for professional/laboratory use only. Theradiag are the market leaders in Therapeutic Drug Monitoring  (TDM) with assays validated and supported by the pharmaceutical industry.